Sign in

CIK 0001813814

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Definium Therapeutics, Inc.

Sign in to watch
Ticker
DFTX
Exchange
Nasdaq
Industry
Medicinal Chemicals & Botanical Products
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
Operating
Phone
+1 212-220-6633
Business address
ONE WORLD TRADE CENTER, SUITE 8500, NEW YORK, NY, 10007
Former names
Mind Medicine (MindMed) Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,023,010
in 6 filings, $3.0M under 10b5-1 plans

Net −$3,023,010. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-11 GRYSKA DAVID W Director Grant or award +4,666 19,900
2026-06-11 GRYSKA DAVID W Director Grant or award · Stock Option (Right to Buy) +19,188 19,188
2025-06-12 GRYSKA DAVID W Director Grant or award · Stock Option (Right to Buy) +75,187 75,187
2024-12-05 GRYSKA DAVID W Director Purchase +2,500 $7.17 $18K 19,851
2024-08-23 GRYSKA DAVID W Director Purchase +3,500 $5.98 $21K 17,351
2024-06-10 GRYSKA DAVID W Director Grant or award · Stock Option (Right to Buy) +16,506 16,506
2023-06-21 GRYSKA DAVID W Director Grant or award +13,851 13,851
2023-06-21 GRYSKA DAVID W Director Grant or award · Stock Option (Right to Buy) +37,594 37,594
2023-06-21 GRYSKA DAVID W Director Grant or award · Director's Deferred Share Units +13,131 13,131

Page 1 of 1 · 9 trades